- English
- Chinese
- French
- German
- Portuguese
- Spanish
- Russian
- Japanese
- Korean
- Arabic
- Irish
- Greek
- Turkish
- Italian
- Danish
- Romanian
- Indonesian
- Czech
- Afrikaans
- Swedish
- Polish
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Albanian
- Amharic
- Armenian
- Azerbaijani
- Belarusian
- Bengali
- Bosnian
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Croatian
- Dutch
- Estonian
- Filipino
- Finnish
- Frisian
- Galician
- Georgian
- Gujarati
- Haitian
- Hausa
- Hawaiian
- Hebrew
- Hmong
- Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kyrgyz
- Latin
- Latvian
- Lithuanian
- Luxembou..
- Macedonian
- Malagasy
- Malay
- Malayalam
- Maltese
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Serbian
- Sesotho
- Sinhala
- Slovak
- Slovenian
- Somali
- Samoan
- Scots Gaelic
- Shona
- Sindhi
- Sundanese
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbek
- Vietnamese
- Welsh
- Xhosa
- Yiddish
- Zulu
- Kinyarwanda
- Tatar
- Oriya
- Turkmen
- Uyghur
Irohin
-
Irohin
awọn aami aiṣan ti akàn ẹdọ 2026: Awọn ami Tuntun & Iye Itọju - Awọn ile-iwosan nitosi mi
Akoonu Loye Awọn ami Tuntun ti Akàn Ẹdọ ni Awọn Okunfa Ewu 2026 ati Tani O yẹ ki o ṣe ayẹwo Awọn ilana Aisan Aisan fun Ijẹrisi Awọn aṣayan Itọju Ẹdọ Akàn Wa ni 2026 Ẹdọ C...
Itọju Ẹdọfóró akàn akọkọ 2026: Awọn Itọsọna Tuntun & Awọn Iwosan Titun
Imọye Akoonu Akàn Ẹdọfóró Alakọbẹrẹ ati Awọn Ilana Imudaniloju Imudojuiwọn Awọn Itọsọna Itọju Ẹdọfóró Ẹdọfóró 2026 fun Awọn Ilọsiwaju Akàn Ẹdọfóró Ẹdọfóró Kekere ni Awọn Itọju Ẹdọfóró Ẹdọfóró Kekere…
Awọn oogun Itọju Akàn Ẹdọfóró 2026: KRAS Tuntun & Awọn Oògùn HER2
Akoonu Akoko Tuntun ti Oogun Itọkasi ni Awọn Ilọsiwaju Akàn Ẹdọfóró ni Awọn Ilọsiwaju Awọn Iwosan-Ifojusi HER2 ni Awọn Itọju Inhibitor KRAS Itankalẹ ti Awọn Itọju Ifojusi EGFR Ifiwera ti Bọtini L...
Iṣẹ abẹ Itọju Ẹdọfóró Akàn 2026: Titun Neo-Adjuvant Breakthroughs
Akoonu Itankalẹ ti Iṣẹ abẹ Itọju Ẹdọfóró ni ọdun 2026 Awọn aṣeyọri ninu Imunotherapy-orisun Neo-Adjuvant Regimens Itọju Itọju fun Awakọ-iyipada Iyipada Awọn Alaisan rere Awọn ilana Iṣẹ abẹ…
Itoju Itọju Ẹdọfóró Ẹdọfóró Ipele Kekere 2026: Iza-bren Tuntun & Tarlatamab Breakthroughs
Akoonu Itankalẹ ti Ipele Itọju Ẹdọfóró Ẹdọfóró Ipele Kekere Iza-bren: Iyipada Paradigm ni Bispecific ADC Therapy Tarlatamab ati Dide ti T-Cell Olukoni Aabo ati Ifarada ni...
Awọn aṣayan Itọju Ẹdọfóró Ẹdọfóró Kekere 2026: ADC Tuntun & Awọn Ipinnu Immunotherapy
Akoonu Akoonu Loye Ilẹ-ilẹ lọwọlọwọ ti Awọn aṣayan Itọju Ẹdọfóró Ẹdọfóró Ẹdọgbọn Kekere Awọn Iṣeduro Laini akọkọ: Awọn akojọpọ Ajẹsara Ajẹsara Dide ti Awọn Asopọmọra Atako-Oògùn (ADCs) Ifojusi DLL3:...
